menu

Pemphigus Vulgaris Market

Schedule Call

Pemphigus Vulgaris Market

Pemphigus Vulgaris Market by [Diagnosis (Histopathology, Direct Immunofluorescence), Treatment (Corticosteroids)], Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies) – Global Outlook & Forecast 2023-2031

GR - 801742 Category: Pharmaceuticals

Number of pages: 100  |  Report Format: PDF  |  Published date: April 13, 2023

Historical Years – 2021  |  Base Year – 2022  |  Forecasted Years – 2023-2031


Pemphigus Vulgaris Market Scope

Report Attribute

Details

Market Size Value in 2022

US$ 459.85 million

Market Size Value in 2031

US$ 863.84 million

CAGR

8.2%

Base Year For Estimation

2022

Forecast Period

2023 to 2031

Historical Year

2021

Segments Covered

Diagnosis and Treatment, Route of Administration, Distribution Channel, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global pemphigus vulgaris market was valued at US$ 459.85 million in 2022 and is expected to register a revenue CAGR of 8.2% to reach US$ 863.84 million by 2031.

Pemphigus Vulgaris Market Fundamentals

The pemphigus vulgaris is a rare autoimmune disorder that affects the skin and mucous membranes. The formation of painful blisters and sores on the skin, mouth, throat, nose, genitals, and anus characterizes it. Pemphigus vulgaris occurs when the immune system mistakenly attacks healthy cells in the body, particularly the proteins that hold skin cells together. This leads to the separation of skin layers and the formation of blisters. Pemphigus vulgaris is typically treated with immunosuppressive drugs, corticosteroids, and biological therapies to manage symptoms and prevent complications. It is important to seek medical attention if you are experiencing symptoms of pemphigus vulgaris to receive prompt diagnosis and treatment.

The pemphigus vulgaris market outlook is positive and is expected to grow during the forecast period, driven by factors such as an increasing prevalence of autoimmune diseases, rising healthcare expenditure, and ongoing research and development efforts. The market is also expected to benefit from the approval of new therapies, which will offer patients more treatment options and improve the standard of care for this condition. 

However, the pemphigus vulgaris market also faces several challenges, including the high cost of treatment, the limited patient population, and the potential for serious side effects associated with current therapies. In addition, there is a need for greater awareness of pemphigus vulgaris among healthcare providers and the general public, which could help improve patient diagnosis and treatment outcomes.

[7565]

Pemphigus Vulgaris Market Dynamics

The global prevalence of pemphigus vulgaris is increasing, driving the pemphigus vulgaris market revenue growth. This is attributed to various factors such as changes in lifestyle, environmental factors, and genetic predisposition. According to the International Pemphigus & Pemphigoid Foundation, pemphigus vulgaris occurs approximately between 0.1 and 2.7 per 100,000 people per year globally. There is a growing focus on research and development of new treatment options for pemphigus vulgaris, including new diagnostic tools, targeted therapies, and personalized medicine approaches. Biologic therapies are becoming increasingly popular in treating pemphigus vulgaris due to their efficacy and fewer side effects compared to other treatment options. This has led to increased market research and the development of biological therapies. 

There is a growing awareness of Pemphigus vulgaris among healthcare providers, leading to earlier diagnosis and prompt treatment. This is expected to fuel the pemphigus vulgaris market revenue growth as more patients seek medical attention. Developing new diagnostic tools and treatment options is another trend observed in the pemphigus vulgaris market. This includes using advanced diagnostic techniques such as ELISA and immunofluorescence and developing targeted therapies. However, the high cost of treatment is restricting the pemphigus vulgaris market growth.

Pemphigus Vulgaris Market Ecosystem

The global pemphigus vulgaris market is analyzed from four perspectives: diagnosis and treatment, route of administration, distribution channel, and region. 

Pemphigus Vulgaris Market by Diagnosis and Treatment

[93546]

Based on the diagnosis, the global pemphigus vulgaris market is segmented into histopathology, direct immunofluorescence, indirect immunofluorescence, and others. 

Direct immunofluorescence is a highly accurate diagnostic method for Pemphigus Vulgaris, with a sensitivity of up to 95% and a specificity of up to 100%. This makes direct immunofluorescence segment an ideal method for confirming the diagnosis of pemphigus vulgaris and distinguishing it from other blistering disorders. Direct immunofluorescence has been used for many years to diagnose pemphigus vulgaris and is a well-established method widely used by healthcare providers, particularly dermatologists and pathologists. This has contributed to its dominance in the pemphigus vulgaris market. Direct immunofluorescence is a relatively simple and cost-effective diagnostic method that can be performed in most clinical laboratories. This has made it accessible to a wide range of healthcare providers and has contributed to its widespread use. Accurately diagnosing pemphigus vulgaris is crucial for initiating appropriate treatment, which can help control symptoms and prevent complications. Direct immunofluorescence plays a key role in this process, making it an important diagnostic method in the pemphigus vulgaris market.

Based on the treatment, the global pemphigus vulgaris market is segmented into corticosteroids, immunosuppressive, biological therapies, intravenous immunoglobulin (IVIG) therapy, and others.

The corticosteroids segment is highly effective in controlling the symptoms of pemphigus vulgaris by suppressing the immune response and reducing inflammation. They are the most widely used and effective treatment options for this disease. Corticosteroids have been used for many years to treat pemphigus vulgaris and are a well-established treatment option that healthcare providers widely use. This has contributed to their dominance in the pemphigus vulgaris market. Corticosteroids are relatively inexpensive and widely available, making them an accessible treatment option for patients with pemphigus vulgaris, thus boosting segmental growth. Corticosteroids are often combined with immunosuppressive drugs to enhance their efficacy and reduce the risk of side effects. This has contributed to their widespread use and dominance in the pemphigus vulgaris market. Although other treatment options are available for pemphigus vulgaris, such as immunosuppressive drugs, these treatments are often used with corticosteroids rather than as a stand-alone treatment. This has contributed to the dominance of the corticosteroid segment in the pemphigus vulgaris market.

The biological therapies segment is expected to experience lucrative revenue growth during the forecast period. Biological therapies target specific molecules or cells involved in the disease process, improving efficacy and reducing side effects compared to traditional non-biological therapies. Biological therapies offer a novel mechanism of action that may be more effective and better tolerated than existing therapies. While corticosteroids and immunosuppressive drugs are the current standard of care for pemphigus vulgaris, they have limitations in terms of efficacy and safety. Therefore, a significant unmet need for more effective and safer therapies has led to increased interest and investment in developing novel biological therapies. Several promising biological therapies for pemphigus vulgaris are currently in clinical trials, and early results have been encouraging, which is also expected to fuel segmental revenue growth. 

Pemphigus Vulgaris Market by Route of Administration

Based on the route of administration, the global pemphigus vulgaris market is segmented into oral, parenteral, and others.

The oral segment had a prominent pemphigus vulgaris market revenue share in 2022. Oral medications, such as corticosteroids and immunosuppressive drugs, are the first-line treatment for pemphigus vulgaris and are typically administered orally. Oral medications have been used for many years to treat pemphigus vulgaris and are a well-established treatment option that healthcare providers widely use. This has contributed to their dominance in the market. Oral medications are convenient, easy to administer, and do not require specialized equipment or medical personnel. This is particularly important for chronic conditions like pemphigus vulgaris, where patients may need to take medications for an extended period. Many patients prefer oral medications over other routes of administration, such as injections or infusions, due to their convenience and ease of use. While other administration routes are available for some medications used to treat pemphigus vulgaris, such as intravenous or subcutaneous injection, these are often reserved for patients who cannot take medications orally. Therefore, the oral route of administration is the most common and dominant route for treating pemphigus vulgaris.

Pemphigus Vulgaris Market by Distribution Channel

Based on the distribution channel, the global pemphigus vulgaris market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

The hospital pharmacies segment dominated the pemphigus vulgaris market with the largest revenue share. Pemphigus vulgaris is a rare autoimmune disease requiring specialized care and treatment, often provided in hospitals. Patients with severe or refractory disease may require hospitalization, which increases the demand for medications from hospital pharmacies. Many medicines used to treat pemphigus vulgaris, such as corticosteroids and immunosuppressive drugs, require close monitoring and dosage adjustments, which hospital pharmacists often manage. In addition, hospital pharmacists are responsible for dispensing medications to inpatients, which can drive demand for medications from hospital pharmacies. Some medications used to treat pemphigus vulgaris, such as biological therapies, may only be available through hospital pharmacies due to their specialized nature and complex administration requirements. This can drive demand for medications from hospital pharmacies. Hospital pharmacists often work closely with healthcare providers, including dermatologists and rheumatologists, responsible for managing pemphigus vulgaris. This collaboration can improve medication adherence and patient outcomes, which can drive demand for medications from hospital pharmacies.

Pemphigus Vulgaris Market by Region

Geographically, the global pemphigus vulgaris market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America has the largest pemphigus vulgaris market size in terms of revenue generation. North America has some of the most advanced healthcare facilities in the world, including specialized dermatology and rheumatology clinics, which are equipped to manage pemphigus vulgaris. This has improved access to care and increased demand for medications. The incidence of pemphigus vulgaris is increasing in North America, fueling the demand for medications and treatments. There have been significant advancements in diagnosing and treating pemphigus vulgaris in North America, improving patient outcomes and increasing demand for medications. The pharmaceutical market in North America is strong and well-developed, which has led to the development of new and innovative drugs and treatments for pemphigus vulgaris.

Competitive Landscape of the Global Pemphigus Vulgaris Market 

The prominent players operating in the global pemphigus vulgaris market are:

Strategic Developments in the Pemphigus Vulgaris Market 

  • In January 2023, Dr. Reddy’s Laboratories Ltd. completed clinical studies of its proposed rituximab biosimilar candidate, DRL_RI, for filing in highly regulated markets such as the United States, Europe, and other regions. DRL_RI is being developed as a biosimilar of rituximab, a cluster of differentiation 20 (CD20) directed cytolytic antibodies for approval in the United States, European Union, and other regions for various indications including treatment of adult patients with rheumatoid arthritis, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, pemphigus vulgaris, granulomatosis with polyangiitis and microscopic polyangiitis.

Frequently Asked Questions About This Report

The expected size of the global pemphigus vulgaris market in 2031 is US$ 863.84 million.

North America accounts for the largest market revenue share, followed by Europe, and Asia Pacific is expected to be the fastest-growing region during the forecast period.

The prominent players operating in the global pemphigus vulgaris market are Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Genentech, Inc., GlaxoSmithKline plc, and Alexion Pharmaceuticals, Inc. (AstraZeneca).

During the forecast period, the revenue CAGR of the global pemphigus vulgaris market is expected to be 8.2%.

The corticosteroids segment dominates the global pemphigus vulgaris market with the largest revenue share.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources 
      1. Secondary Sources 
      2. Primary Sources  
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape 
    4. Reimbursement Scenario 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL PEMPHIGUS VULGARIS MARKET - ANALYSIS & FORECAST, BY DIAGNOSIS AND TREATMENT 
    1. Diagnosis 
      1. Histopathology
      2. Direct Immunofluorescence
      3. Indirect Immunofluorescence
      4. Others
    2. Treatment
      1. Corticosteroids
      2. Immunosuppressive
      3. Biological Therapies
      4. Intravenous Immunoglobulin (IVIG) Therapy
      5. Others
  6. GLOBAL PEMPHIGUS VULGARIS MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
    1. Oral
    2. Parenteral
    3. Others
  7. GLOBAL PEMPHIGUS VULGARIS MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
    1. Hospital Pharmacies 
    2. Retail Pharmacies
    3. Online Pharmacies
  8. GLOBAL PEMPHIGUS VULGARIS MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Pemphigus Vulgaris Market
      1. North America Pemphigus Vulgaris Market, by Diagnosis and Treatment 
      2. North America Pemphigus Vulgaris Market, By Route of Administration
      3. North America Pemphigus Vulgaris Market, by Distribution Channel
      4. North America Pemphigus Vulgaris Market, by Country
        1. U.S.
          1. U.S. Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. U.S. Pemphigus Vulgaris Market, By Route of Administration
          3. U.S. Pemphigus Vulgaris Market, by Distribution Channel
        2. Canada
          1. Canada Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Canada Pemphigus Vulgaris Market, By Route of Administration
          3. Canada Pemphigus Vulgaris Market, by Distribution Channel
    2. Europe Pemphigus Vulgaris Market
      1. Europe Pemphigus Vulgaris Market, by Diagnosis and Treatment 
      2. Europe Pemphigus Vulgaris Market, By Route of Administration
      3. Europe Pemphigus Vulgaris Market, by Distribution Channel
      4. Europe Pemphigus Vulgaris Market, by Country/Region
        1. Germany
          1. Germany Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Germany Pemphigus Vulgaris Market, By Route of Administration
          3. Germany Pemphigus Vulgaris Market, by Distribution Channel
        2. U.K.
          1. U.K. Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. U.K. Pemphigus Vulgaris Market, By Route of Administration
          3. U.K. Pemphigus Vulgaris Market, by Distribution Channel
        3. France
          1. France Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. France Pemphigus Vulgaris Market, By Route of Administration
          3. France Pemphigus Vulgaris Market, by Distribution Channel
        4. Spain
          1. Spain Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Spain Pemphigus Vulgaris Market, By Route of Administration
          3. Spain Pemphigus Vulgaris Market, by Distribution Channel
        5. Italy
          1. Italy Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Italy Pemphigus Vulgaris Market, By Route of Administration
          3. Italy Pemphigus Vulgaris Market, by Distribution Channel
        6. Rest of Europe 
          1. Rest of Europe Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Rest of Europe Pemphigus Vulgaris Market, By Route of Administration
          3. Rest of Europe Pemphigus Vulgaris Market, by Distribution Channel
    3. Asia Pacific Pemphigus Vulgaris Market
      1. Asia Pacific Pemphigus Vulgaris Market, by Diagnosis and Treatment 
      2. Asia Pacific Pemphigus Vulgaris Market, By Route of Administration
      3. Asia Pacific Pemphigus Vulgaris Market, by Distribution Channel
      4. Asia Pacific Pemphigus Vulgaris Market, by Country/Region
        1. China
          1. China Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. China Pemphigus Vulgaris Market, By Route of Administration
          3. China Pemphigus Vulgaris Market, by Distribution Channel
        2. Japan
          1. Japan Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Japan Pemphigus Vulgaris Market, By Route of Administration
          3. Japan Pemphigus Vulgaris Market, by Distribution Channel
        3. India
          1. India Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. India Pemphigus Vulgaris Market, By Route of Administration
          3. India Pemphigus Vulgaris Market, by Distribution Channel
        4. South Korea
          1. South Korea Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. South Korea Pemphigus Vulgaris Market, By Route of Administration
          3. South Korea Pemphigus Vulgaris Market, by Distribution Channel
        5. Australia
          1. Australia Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Australia Pemphigus Vulgaris Market, By Route of Administration
          3. Australia Pemphigus Vulgaris Market, by Distribution Channel
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Rest of Asia Pacific Pemphigus Vulgaris Market, By Route of Administration
          3. Rest of Asia Pacific Pemphigus Vulgaris Market, by Distribution Channel
    4. Rest Latin America Pemphigus Vulgaris Market
      1. Latin America Pemphigus Vulgaris Market, by Diagnosis and Treatment 
      2. Latin America Pemphigus Vulgaris Market, By Route of Administration
      3. Latin America Pemphigus Vulgaris Market, by Distribution Channel
      4. Latin America Pemphigus Vulgaris Market, by Country/ Region
        1. Brazil
          1. Brazil Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Brazil Pemphigus Vulgaris Market, By Route of Administration
          3. Brazil Pemphigus Vulgaris Market, by Distribution Channel
        2. Mexico
          1. Mexico Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Mexico Pemphigus Vulgaris Market, By Route of Administration
          3. Mexico Pemphigus Vulgaris Market, by Distribution Channel
        3. Argentina
          1. Argentina Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Argentina Pemphigus Vulgaris Market, By Route of Administration
          3. Argentina Pemphigus Vulgaris Market, By Route of Administration
        4. Rest of Latin America
          1. Rest of Latin America Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Rest of Latin America Pemphigus Vulgaris Market, By Route of Administration
          3. Rest of Latin America Pemphigus Vulgaris Market, by Distribution Channel 
    5. Middle East & Africa Pemphigus Vulgaris Market
      1. Middle East & Africa Pemphigus Vulgaris Market, by Diagnosis and Treatment 
      2. Middle East & Africa Pemphigus Vulgaris Market, By Route of Administration
      3. Middle East & Africa Pemphigus Vulgaris Market, by Distribution Channel 
      4. Middle East & Africa Pemphigus Vulgaris Market, by Country/ Region
        1. GCC Countries
          1. GCC Countries Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. GCC Countries Pemphigus Vulgaris Market, By Route of Administration
          3. GCC Countries Pemphigus Vulgaris Market, by Distribution Channel
        2. South Africa
          1. South Africa Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. South Africa Pemphigus Vulgaris Market, By Route of Administration
          3. South Africa Pemphigus Vulgaris Market, by Distribution Channel
        3. Rest of Middle East & Africa
          1. Rest of Middle East & Africa Pemphigus Vulgaris Market, by Diagnosis and Treatment 
          2. Rest of Middle East & Africa Pemphigus Vulgaris Market, By Route of Administration
          3. Rest of Middle East & Africa Pemphigus Vulgaris Market, by Distribution Channel
  9. COMPANY PROFILES        
    1. Novartis AG
      1. Business Snapshot
      2. Products Offered
      3. Financial Details*
      4. Strategic Development
    2. Pfizer Inc.
    3. F. Hoffmann-La Roche Ltd
    4. Genentech, Inc.
    5. GlaxoSmithKline Plc
    6. Alexion Pharmaceuticals, Inc. (AstraZeneca)
    7. Vifor Pharma Management Ltd.
    8. Amgen Inc.
    9. Boehringer Ingelheim International GmbH
    10. Principia Biopharma Inc.

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

 

  1. Global Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million)
  2. Global Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  3. Global Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  4. Global Pemphigus Vulgaris Market, by Region, 2021-2031 (US$ Million) 
  5. North America Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  6. North America Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million) 
  7. North America Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  8. North America Pemphigus Vulgaris Market, by Country, 2021-2031 (US$ Million) 
  9. U.S. Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  10. U.S. Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million) 
  11. U.S. Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  12. Canada Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  13. Canada Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million) 
  14. Canada Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  15. Europe Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  16. Europe Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  17. Europe Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  18. Europe Pemphigus Vulgaris Market, by Country/ Region, 2021-2031 (US$ Million) 
  19. Germany Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  20. Germany Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  21. Germany Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  22. U.K. Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  23. U.K. Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  24. U.K. Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  25. France Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  26. France Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  27. France Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  28. Italy Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  29. Italy Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  30. Italy Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  31. Spain Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  32. Spain Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  33. Spain Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  34. Rest of Europe Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million)
  35. Rest of Europe Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  36. Rest of Europe Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  37. Asia Pacific Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  38. Asia Pacific Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  39. Asia Pacific Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  40. Asia Pacific Pemphigus Vulgaris Market, by Country/ Region, 2021-2031 (US$ Million) 
  41. China Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million)
  42. China Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  43. China Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  44. Japan Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million)
  45. Japan Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  46. Japan Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  47. India Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million)
  48. India Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  49. India Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  50. South Korea Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  51. South Korea Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  52. South Korea Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  53. Australia Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million)
  54. Australia Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  55. Australia Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  56. Rest of Asia Pacific Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  57. Rest of Asia Pacific Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  58. Rest of Asia Pacific Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  59. Latin America Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  60. Latin America Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  61. Latin America Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  62. Brazil Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  63. Brazil Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  64. Brazil Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  65. Mexico Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  66. Mexico Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  67. Mexico Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  68. Argentina Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  69. Argentina Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  70. Argentina Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  71. Rest of Latin America Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  72. Rest of Latin America Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  73. Rest of Latin America Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  74. Middle East and Africa Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  75. Middle East and Africa Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million) 
  76. Middle East and Africa Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 
  77. GCC Countries Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  78. GCC Countries Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  79. GCC Countries Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  80. South Africa Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  81. South Africa Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million)
  82. South Africa Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million)
  83. Rest of Middle East and Africa Pemphigus Vulgaris Market, by Diagnosis and Treatment, 2021-2031 (US$ Million) 
  84. Rest of Middle East and Africa Pemphigus Vulgaris Market, By Route of Administration, 2021-2031 (US$ Million) 
  85. Rest of Middle East and Africa Pemphigus Vulgaris Market, by Distribution Channel, 2021-2031 (US$ Million) 

List of Figures

 

  1. Pemphigus Vulgaris Market Ecosystem  
  2. Snapshot of Global Pemphigus Vulgaris Market, 2021 & 2031 
  3. Snapshot of Global Pemphigus Vulgaris Market, by Region, 2021 & 2031 
  4. Global Pemphigus Vulgaris Market: COVID-19 Pandemic Impact Assessment 
  5. Global Pemphigus Vulgaris Market: Key Players & Competitive Positioning (2022) 
  6. Pemphigus Vulgaris: Market Dynamics 
  7. Global Pemphigus Vulgaris Market for Diagnosis, 2021-2031 (US$ Million) 
  8. Global Pemphigus Vulgaris Market for Histopathology, 2021-2031 (US$ Million) 
  9. Global Pemphigus Vulgaris Market for Direct Immunofluorescence, 2021-2031 (US$ Million) 
  10. Global Pemphigus Vulgaris Market for Indirect Immunofluorescence, 2021-2031 (US$ Million) 
  11. Global Pemphigus Vulgaris Market for Others, 2021-2031 (US$ Million) 
  12. Global Pemphigus Vulgaris Market for Treatment, 2021-2031 (US$ Million) 
  13. Global Corticosteroids for Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  14. Global Immunosuppressive for Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  15. Global Biological Therapies for Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  16. Global Intravenous Immunoglobulin (IVIG) Therapy for Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  17. Global Pemphigus Vulgaris Market for Others, 2021-2031 (US$ Million) 
  18. Global Pemphigus Vulgaris Market for Oral, 2021-2031 (US$ Million) 
  19. Global Pemphigus Vulgaris Market for Parenteral, 2021-2031 (US$ Million) 
  20. Global Pemphigus Vulgaris Market for Others, 2021-2031 (US$ Million) 
  21. Global Pemphigus Vulgaris Market for Hospital Pharmacies, 2021-2031 (US$ Million) 
  22. Global Pemphigus Vulgaris Market for Retail Pharmacies, 2021-2031 (US$ Million) 
  23. Global Pemphigus Vulgaris Market for Online Pharmacies, 2021-2031 (US$ Million) 
  24. North America Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  25. U.S. Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  26. Canada Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  27. Europe Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  28. Germany Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  29. U.K. Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  30. France Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  31. Italy Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  32. Spain Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  33. Rest of Europe Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  34. Asia Pacific Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  35. China Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  36. Japan Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  37. India Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  38. South Korea Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  39. Australia Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  40. Rest of Asia Pacific Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  41. Latin America Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  42. Brazil Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  43. Mexico Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  44. Argentina Pemphigus Vulgaris Market, 2021-2031 (US$ Million)
  45. Rest of Latin America Pemphigus Vulgaris Market, 2021-2031 (US$ Million)
  46. Middle East & Africa Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  47. GCC Countries Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  48. South Africa Pemphigus Vulgaris Market, 2021-2031 (US$ Million) 
  49. Rest of Middle East & Africa Pemphigus Vulgaris Market, 2021-2031 (US$ Million)
  50. Novartis AG Revenue from 2019 Onwards (US$ Million)
  51. Pfizer Inc. Revenue from 2019 Onwards (US$ Million)
  52. F. Hoffmann-La Roche Ltd Revenue from 2019 Onwards (US$ Million)
  53. Genentech, Inc. Revenue from 2019 Onwards (US$ Million)
  54. GlaxoSmithKline Plc Revenue from 2019 Onwards (US$ Million)
  55. Alexion Pharmaceuticals, Inc. (AstraZeneca) Revenue from 2019 Onwards (US$ Million)
  56. Vifor Pharma Management Ltd. Revenue from 2019 Onwards (US$ Million)
  57. Amgen Inc. Revenue from 2019 Onwards (US$ Million)
  58. Boehringer Ingelheim International GmbH Revenue from 2019 Onwards (US$ Million)
  59. Principia Biopharma Inc. Revenue from 2019 Onwards (US$ Million)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Pemphigus Vulgaris Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Pemphigus Vulgaris Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports